Human CYP2C19,Low-Reductase

• UNSPSC Description :

  Human CYP2C19, Low-Reductase, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].

• Target Antigen :

  Cytochrome P450

• Type :

  Enzyme

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/human-cyp2c19-low-reductase.html

• Smiles :

  [HumanCYP2C19,Low-Reductase]

• References & Citations :

  [1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.

• Shipping Conditions :

  Room temperature

• Clinical Information :

  No Development Reported